GETI.B

214

+0.71%↑

CAMX

597

-2.77%↓

BIOAB

319.6

-1.72%↓

EKTA.B

56.4

+0.27%↑

VITR

134.6

-0.59%↓

GETI.B

214

+0.71%↑

CAMX

597

-2.77%↓

BIOAB

319.6

-1.72%↓

EKTA.B

56.4

+0.27%↑

VITR

134.6

-0.59%↓

GETI.B

214

+0.71%↑

CAMX

597

-2.77%↓

BIOAB

319.6

-1.72%↓

EKTA.B

56.4

+0.27%↑

VITR

134.6

-0.59%↓

GETI.B

214

+0.71%↑

CAMX

597

-2.77%↓

BIOAB

319.6

-1.72%↓

EKTA.B

56.4

+0.27%↑

VITR

134.6

-0.59%↓

GETI.B

214

+0.71%↑

CAMX

597

-2.77%↓

BIOAB

319.6

-1.72%↓

EKTA.B

56.4

+0.27%↑

VITR

134.6

-0.59%↓

Home・Akciju saraksts・Vivesto AB

Vivesto AB

Slēgts

0.22

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.22

Max

0.22

Galvenie mērījumi
By Trading Economics
Ienākumi	2.3M -7.2M
EPS	-0.013
Darbinieki	4

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-8.3M 70M
Iepriekšējā atvēršanas cena	0.22
Iepriekšējā slēgšanas cena	0.22

Vivesto AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 15. dec. 17:39 UTC

Galvenie tirgus virzītāji

Vanda Pharmaceuticals Rises on FDA Biologics License Application

2025. g. 15. dec. 23:44 UTC

Tirgus saruna

Gold Steady Ahead of U.S. Employment Report -- Market Talk

2025. g. 15. dec. 23:38 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 15. dec. 23:38 UTC

Tirgus saruna

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

2025. g. 15. dec. 22:19 UTC

Tirgus saruna

Clean-Energy Project Developers Benefit From 'Deep Buyer Universe' -- Market Talk

2025. g. 15. dec. 21:50 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Tech, Media & Telecom Roundup: Market Talk

2025. g. 15. dec. 21:42 UTC

Iegādes, apvienošanās, pārņemšana

Comcast Spinoff Versant Debuts at Modest Valuation, a Signal for a Warner Bros. Sale -- Barrons.com

2025. g. 15. dec. 21:32 UTC

Iegādes, apvienošanās, pārņemšana

Comcast Spinoff Versant Debuts at Modest Valuation, Puts Warner Bros. Discovery in Focus -- Barrons.com

2025. g. 15. dec. 21:28 UTC

Iegādes, apvienošanās, pārņemšana

iRobot Files for Bankruptcy After Amazon Was Forced to Scrap Its Deal to Buy the Roomba Maker -- Barrons.com

2025. g. 15. dec. 21:26 UTC

Iegādes, apvienošanās, pārņemšana

Commercial Metals Completes Acquisition of Foley Products for $1.84B >CMC

2025. g. 15. dec. 21:23 UTC

Iegādes, apvienošanās, pārņemšana

Perseus Mining: Reserves Right to Make Further Proposal If Circumstances Change

2025. g. 15. dec. 21:23 UTC

Iegādes, apvienošanās, pārņemšana

Perseus Mining: Does Not Intend to Submit Revised Takeover Proposal For Predictive

2025. g. 15. dec. 21:23 UTC

Iegādes, apvienošanās, pārņemšana

Perseus Mining: Notes Predictive Shares Trade at Discount to Value Implied By Perseus Proposal

2025. g. 15. dec. 21:22 UTC

Iegādes, apvienošanās, pārņemšana

Perseus Mining: Believes Revised Robex Merger Inferior to Its Own Takeover Proposal

2025. g. 15. dec. 21:20 UTC

Iegādes, apvienošanās, pārņemšana

Commercial Metals Completes Acquisition Of Foley Products Company >CMC

2025. g. 15. dec. 21:15 UTC

Iegādes, apvienošanās, pārņemšana

ServiceNow Completes Acquisition Of Moveworks >NOW

2025. g. 15. dec. 21:00 UTC

Iegādes, apvienošanās, pārņemšana

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

2025. g. 15. dec. 20:57 UTC

Iegādes, apvienošanās, pārņemšana

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

2025. g. 15. dec. 20:36 UTC

Tirgus saruna

Oil Futures Fall Further on Oversupply Concerns -- Market Talk

2025. g. 15. dec. 20:31 UTC

Tirgus saruna

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

2025. g. 15. dec. 20:27 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

ServiceNow's Acquisition Streak Could Cause Investor Angst -- Market Talk

2025. g. 15. dec. 20:15 UTC

Tirgus saruna

El Buen Fin Helps Lift Mexican November Retail Sales -- Market Talk

2025. g. 15. dec. 19:22 UTC

Tirgus saruna

Gold and Silver Gain to Start Week -- Market Talk

2025. g. 15. dec. 18:37 UTC

Tirgus saruna

Oil Futures Extend Losses On Oversupply Worries -- Market Talk

2025. g. 15. dec. 18:29 UTC

Tirgus saruna

ServiceNow Seen Facing Pressure if Government Budgets Decline -- Market Talk

2025. g. 15. dec. 17:58 UTC

Tirgus saruna

Canada Housing Market In Search Of a Bottom -- Market Talk

2025. g. 15. dec. 17:36 UTC

Tirgus saruna

Canada Data Signal Underlying Price Pressures Persist -- Market Talk

2025. g. 15. dec. 17:36 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 15. dec. 17:36 UTC

Peļņas

Texas Instruments Stock Slips. It Caught a Rare Downgrade From Goldman Sachs. -- Barrons.com

2025. g. 15. dec. 17:30 UTC

Iegādes, apvienošanās, pārņemšana

Cinemark Stock Could Fall Even More If Netflix Buys Warner Bros., Analyst Says -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Vivesto AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.